High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2
Authors:
- 12 April 2010
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 107 (17) , 7904-7909
Abstract
MicroRNAs (miRNAs) are noncoding RNAs that regulate global gene expression. miRNAs often act synergistically to repress target genes, and their dysregulation can contribute to the initiation and progression of a variety of cancers. The clinical relationship between global expression of miRNA and mRNA in cancer has not been studied in detail. We used whole-genome microarray analyses of CD138-enriched plasma cells from 52 newly diagnosed cases of multiple myeloma to correlate miRNA expression profiles with a validated mRNA-based risk stratification score, proliferation index, and predefined gene sets. In stark contrast to mRNAs, we discovered that all tested miRNAs were significantly up-regulated in high-risk disease as defined by a validated 70-gene risk score ( P < 0.01) and proliferation index ( P < 0.05). Increased expression of EIF2C2/AGO2 , a master regulator of the maturation and function of miRNAs and a component of the 70-gene mRNA risk model, is driven by DNA copy number gains in MM. Silencing of AGO2 dramatically decreased viability in MM cell lines. Genome-wide elevated expression of miRNAs in high-risk MM may be secondary to deregulation of AGO2 and the enzyme complexes that regulate miRNA maturation and function.Keywords
This publication has 38 references indexed in Scilit:
- Dicer, Drosha, and Outcomes in Patients with Ovarian CancerNew England Journal of Medicine, 2008
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesisProceedings of the National Academy of Sciences, 2008
- Widespread microRNA repression by Myc contributes to tumorigenesisNature Genetics, 2007
- miRBase: tools for microRNA genomicsNucleic Acids Research, 2007
- A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathwayGenes & Development, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Silencing of microRNAs in vivo with ‘antagomirs’Nature, 2005
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- c-Myc-regulated microRNAs modulate E2F1 expressionNature, 2005
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001